SEARCH:
Charting a New Course in Regenerative Medicine
ISTO Technologies is an orthobiologics company focused on developing breakthrough products to regenerate and restore function to damaged cartilage and bone.
 |  |  |
| Bone Graft Extender & Substitute for Spinal Fusion | Injectable Cartilage Cells for Disc Regeneration | Engineered Cartilage for Knee Injuries |
Media & Events
News
- Jan 6, 2012 ISTO Technologies to Participate in Panel Session for the Regenerative Medicine... >> Read More
- Oct 13, 2011 ISTO Technologies Receives CE Mark for InQu® Bone Graft Substitute and Extender >> Read More
- Feb 7, 2011 ISTO Awarded Key Patent for NuQuâ„¢ Injectable Therapy for Degenerative Disc... >> Read More
- Nov 29, 2010 ISTO Technologies to present at the 22nd Annual Piper Jaffray Health Care Conference >> Read More
- Oct 5, 2010 ISTO Technologies Completes Enrollment in Phase I NuQuâ„¢ Clinical Trial >> Read More
- Jul 26, 2010 ISTO Technologies, Inc. to present at the BMO Capital Markets 10th Annual Focus... >> Read More
- May 12, 2010 ISTO Technologies Announces Release of Peer-Reviewed Scientific Publication... >> Read More
- Feb 26, 2010 Translational Regenerative Medicine Event Features Venture Forum >> Read More
- Feb 16, 2010 ISTO Technologies Inc. to Present at the Canaccord Adams Musculoskeletal Conference >> Read More
- Apr 28, 2009 ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial... >> Read More
Video
Watch our videos and learn more about Isto Technologies and our innovative products. View All Videos
 |
| [Isto Company Video] |